This topic contains a solution. Click here to go to the answer

Author Question: How would a chemical that prevents the opening of voltage-regulated Na+ channels affect the function ... (Read 39 times)

newyorker26

  • Hero Member
  • *****
  • Posts: 536
How would a chemical that prevents the opening of voltage-regulated Na+ channels affect the function of a neuron?
 A) The neuron will only be able to hyperpolarize.
  B) The neuron will depolarize more rapidly.
  C) Action potentials will lack a repolarization phase.
  D) The neuron will automatically and repeatedly produce graded potentials.
  E) The neuron will only be capable of producing graded potentials.

Question 2

During repolarization of a neuron
 A) sodium ions move out of the cell.
  B) potassium ions move out of the cell.
  C) potassium ions move into the cell.
  D) both sodium and potassium ions move into the cell.
  E) sodium ions move into the cell.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Kedrick2014

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

E

Answer to Question 2

B




newyorker26

  • Member
  • Posts: 536
Reply 2 on: Feb 28, 2019
Thanks for the timely response, appreciate it


31809pancho

  • Member
  • Posts: 317
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library